HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,322,292 | +2.0% | 113,149 | -3.6% | 0.01% | +16.7% |
Q2 2023 | $4,235,880 | -10.4% | 117,435 | -5.1% | 0.01% | -14.3% |
Q1 2023 | $4,726,624 | -39.8% | 123,766 | -10.4% | 0.01% | -44.0% |
Q4 2022 | $7,856,638 | +41.1% | 138,078 | -1.9% | 0.02% | +38.9% |
Q3 2022 | $5,568,000 | -12.9% | 140,812 | -3.1% | 0.02% | +5.9% |
Q2 2022 | $6,391,000 | -15.1% | 145,256 | -23.0% | 0.02% | +6.2% |
Q1 2022 | $7,525,000 | -0.8% | 188,700 | 0.0% | 0.02% | +6.7% |
Q4 2021 | $7,588,000 | -0.4% | 188,700 | +0.7% | 0.02% | -6.2% |
Q3 2021 | $7,619,000 | -10.4% | 187,300 | 0.0% | 0.02% | -11.1% |
Q2 2021 | $8,505,000 | +9.9% | 187,300 | +0.9% | 0.02% | +12.5% |
Q1 2021 | $7,738,000 | -8.4% | 185,600 | -6.2% | 0.02% | -20.0% |
Q4 2020 | $8,452,000 | +39.7% | 197,900 | -14.1% | 0.02% | +33.3% |
Q3 2020 | $6,052,000 | +3.6% | 230,300 | +5.7% | 0.02% | -6.2% |
Q2 2020 | $5,842,000 | +56.3% | 217,900 | +4.9% | 0.02% | +33.3% |
Q1 2020 | $3,737,000 | -1.6% | 207,700 | -3.0% | 0.01% | +20.0% |
Q4 2019 | $3,796,000 | +14.3% | 214,100 | 0.0% | 0.01% | +11.1% |
Q3 2019 | $3,321,000 | +6.6% | 214,100 | +18.1% | 0.01% | 0.0% |
Q2 2019 | $3,115,000 | +11.8% | 181,300 | +4.8% | 0.01% | +12.5% |
Q1 2019 | $2,785,000 | +48.1% | 173,000 | +34.6% | 0.01% | +33.3% |
Q4 2018 | $1,880,000 | -18.6% | 128,500 | +1.1% | 0.01% | 0.0% |
Q3 2018 | $2,309,000 | +7.7% | 127,100 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $2,144,000 | -7.2% | 127,100 | +7.8% | 0.01% | -14.3% |
Q1 2018 | $2,310,000 | -3.3% | 117,900 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $2,389,000 | +71.9% | 117,900 | +47.4% | 0.01% | +75.0% |
Q3 2017 | $1,390,000 | +35.5% | 80,000 | 0.0% | 0.00% | +33.3% |
Q2 2017 | $1,026,000 | -78.7% | 80,000 | -84.0% | 0.00% | -82.4% |
Q4 2014 | $4,825,000 | +103.9% | 500,000 | +92.3% | 0.02% | +88.9% |
Q3 2014 | $2,366,000 | – | 260,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
2Xideas AG | 600,799 | $22,950,522 | 2.54% |
BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |